BIVICTRIX THERAPEUTICS LIMITED

Company number 10005270

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
08 Oct 2020 AA Accounts for a small company made up to 31 December 2019
28 Aug 2020 SH01 Statement of capital following an allotment of shares on 17 April 2020
  • GBP 1,075.77
14 Jul 2020 RP04SH01 Second filing of a statement of capital following an allotment of shares on 15 October 2019
  • GBP 1,004.33
12 Jun 2020 RP04SH01 Second filing of a statement of capital following an allotment of shares on 11 June 2019
  • GBP 960.85
12 Jun 2020 RP04SH01 Second filing of a statement of capital following an allotment of shares on 30 July 2019
  • GBP 989.18
06 Apr 2020 TM01 Termination of appointment of Michael Greenwood Carter as a director on 31 March 2020
26 Mar 2020 CS01 Confirmation statement made on 14 February 2020 with updates
15 Oct 2019 SH01 Statement of capital following an allotment of shares on 6 October 2019
  • GBP 932.47
  • ANNOTATION Clarification a second filed SH01 was registered on 14/07/2020.
01 Oct 2019 AA Accounts for a small company made up to 31 December 2018
16 Sep 2019 SH01 Statement of capital following an allotment of shares on 11 June 2019
  • GBP 989.19
  • ANNOTATION Clarification a second filed SH01 was registered on 12/06/2020.
04 Sep 2019 SH01 Statement of capital following an allotment of shares on 30 July 2019
  • GBP 917.32
  • ANNOTATION Clarification a second filed SH01 was registered on 12/06/2020.
26 Jun 2019 AP01 Appointment of Dr Michael Greenwood Carter as a director on 25 May 2019
30 May 2019 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
28 Mar 2019 PSC02 Notification of Development Bank of Wales as a person with significant control on 28 March 2019
28 Mar 2019 PSC09 Withdrawal of a person with significant control statement on 28 March 2019
07 Mar 2019 CS01 Confirmation statement made on 14 February 2019 with updates
21 Jan 2019 AP01 Appointment of Mr Norman Molyneux as a director on 29 November 2018
12 Dec 2018 TM01 Termination of appointment of David William Youngman as a director on 29 November 2018
29 Nov 2018 SH01 Statement of capital following an allotment of shares on 13 June 2018
  • GBP 917.32
25 Oct 2018 TM01 Termination of appointment of Christopher Doherty as a director on 20 October 2018
22 Jun 2018 AA Accounts for a small company made up to 31 December 2017
30 Apr 2018 AP01 Appointment of Mr Christopher Doherty as a director on 1 March 2018
27 Feb 2018 CS01 Confirmation statement made on 14 February 2018 with no updates
21 Feb 2018 SH08 Change of share class name or designation
20 Feb 2018 SH10 Particulars of variation of rights attached to shares